Multiple Myeloma Therapeutics Market Future Scope, Demands and Projected Industry Growths to 2035
The global multiple myeloma therapeutics market was valued at USD 26.62 billion in 2025 and is projected to exceed USD 47.67 billion by 2035, growing at a compound annual growth rate (CAGR) of over 6% during the forecast period.
The market is witnessing steady expansion due to increasing incidence of hematologic malignancies, advancements in targeted therapies, and the growing availability of innovative treatment regimens. Continuous research and development, along with improved survival rates, are further contributing to sustained market growth.